A detailed history of Bergan Kdv Wealth Management, LLC transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Bergan Kdv Wealth Management, LLC holds 10,000 shares of RIGL stock, worth $150,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$150,800
Previous $13,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

BUY
$2.36 - $3.57 $8,260 - $12,495
3,500 Added 53.85%
10,000 $27,000
Q2 2020

Aug 13, 2020

BUY
$1.41 - $2.05 $5,640 - $8,200
4,000 Added 160.0%
6,500 $12,000
Q2 2018

Jul 23, 2018

BUY
$2.83 - $4.11 $7,075 - $10,275
2,500 New
2,500 $7,000

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.61B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Bergan Kdv Wealth Management, LLC Portfolio

Follow Bergan Kdv Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.